| Date Filed | Type | Description |
| 01/17/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2022 |
4
| TAYTON-MARTIN HELEN KATRINA (Chief Business Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Granted 1,407,072 options to buy
@ $0
Granted 314,256 options to buy
@ $0 |
|
| 11/19/2021 |
4
| TAYTON-MARTIN HELEN KATRINA (Director) has filed a Form 4 on Trillium Therapeutics Inc.|
Txns:
| Disposed/sold 40,000 options to buy
@ $12.03, valued at
$481.2k
Disposed/sold 498,294 restricted stock units
@ $0 |
|
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/17/2020 |
4
| TAYTON-MARTIN HELEN KATRINA (Chief Business Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Granted 1,257,744 options to buy
@ $0
Granted 280,896 options to buy
@ $0 |
|
| 01/15/2020 |
4
| TAYTON-MARTIN HELEN KATRINA (Chief Business Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Sold 50,000 shares
@ $4, valued at
$200k
Sold 50,000 shares
@ $5, valued at
$250k
|
|
| 01/08/2019 |
4
| TAYTON-MARTIN HELEN KATRINA (Chief Business Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Granted 1,006,224 options to buy
@ $0
Granted 224,724 options to buy
@ $0 |
|
| 01/17/2018 |
4
| TAYTON-MARTIN HELEN KATRINA (Chief Business Officer) has filed a Form 4 on Adaptimmune Therapeutics PLC|
Txns:
| Granted 687,984 options to buy
@ $0
Granted 153,648 options to buy
@ $0 |
|
| 01/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |